Doncaster Communication Change of inhaler Soprobec 250 (from Clenil) 2526.pdf

Doncaster Communication Change of inhaler Soprobec 200 (from Clenil) 2526 - Copy.pdf

Doncaster Communication Change of inhaler Soprobec 100 (from Clenil) 2526.pdf

Doncaster Communication Change of inhaler Soprobec 50 (from Clenil) 2526.pdf

Doncaster Communication Dose optimisation and quantity synchronisation SOP V6.0.pdf

Doncaster Communication SOP formulation change V4.0.pdf

Doncaster Communication Soprobec action sheet QIPP 2025_2026.pdf

Doncaster Communication Switching from Brand to generic SOP V5.0.pdf

Doncaster Communication Switching from generic or branded to a specific brand V6.0 Rev Oct 2027.pdf

Doncaster Minutes PMOC March 2026 Section 1&2 .pdf

Doncaster Guideline SSRIs for premature ejaculation Sept 2022.pdf

Doncaster Guideline Hormone replacement therapy March 2025.pdf

Doncaster Guideline HRT with unscheduled bleeding June 2024.pdf

Doncaster Shared Care Testosterone SCP Dec 2025 V1.1.pdf

Doncaster Guideline Opioid Prescribing Resource in Chronic Non-Cancer Pain Including Tapering Advice July 2024 .pdf

Doncaster Communication Change of inhaler Soprobec 250 (from Clenil) 2526.pdf

Doncaster Guideline Vitamin D guideline Children and Young People V3.1 Jan 26.pdf

Doncaster Shared Care Topical testosterone replacement therapy in menopausal women July 2023.pdf

Doncaster Guideline Ocular lubricant prescribing Updated Oct 25 V2.1.pdf

Doncaster Guideline Emollient Prescribing Guidance for long term conditions only Sep 2024.pdf